Noriko Masubuchi

596 total citations
17 papers, 450 citations indexed

About

Noriko Masubuchi is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Noriko Masubuchi has authored 17 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Noriko Masubuchi's work include Drug Transport and Resistance Mechanisms (8 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Noriko Masubuchi is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Noriko Masubuchi collaborates with scholars based in Japan, United States and Germany. Noriko Masubuchi's co-authors include Osamu Okazaki, Nobuyuki Murayama, Hideo Hakusui, Albert P. Li, Katsushi Amano, Tomokazu Matsuura, Μakoto Tanaka, Ryo Atsumi, Richard May and Noriko Okudaira and has published in prestigious journals such as Clinical Cancer Research, Biochemical Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Noriko Masubuchi

17 papers receiving 428 citations

Peers

Noriko Masubuchi

ONCOL

PHARM

RNMI

SURGE

David J. Sweeny United States

Aaron M. Moss United States

Song Ling Poon Canada

Yasuro KAWAGUCHI Japan

Dianne Hammond United States

Kazumasa Ikeda Japan

Nobuyuki Murayama Japan

Suzanne Tay United States

Joe Palandra United States

David J. Sweeny United States

Noriko Masubuchi

128 ×0.8

ONCOL

153 ×1.0

88 ×0.6

PHARM

24 ×0.4

RNMI

22 ×0.4

SURGE

Citations per year, relative to Noriko Masubuchi Noriko Masubuchi (= 1×) peers David J. Sweeny

Countries citing papers authored by Noriko Masubuchi

Since Specialization

Citations

This map shows the geographic impact of Noriko Masubuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Masubuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Masubuchi more than expected).

Fields of papers citing papers by Noriko Masubuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Masubuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Masubuchi. The network helps show where Noriko Masubuchi may publish in the future.

Co-authorship network of co-authors of Noriko Masubuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Masubuchi. A scholar is included among the top collaborators of Noriko Masubuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Masubuchi. Noriko Masubuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Masubuchi, Noriko, et al.. (2015). Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development. Chemico-Biological Interactions. 255. 74–82. 22 indexed citations

Masubuchi, Noriko, et al.. (2015). Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis. Chemico-Biological Interactions. 255. 83–91. 27 indexed citations

Amano, Katsushi, et al.. (2015). Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease. Gastroenterology Research and Practice. 2015. 1–10. 45 indexed citations

Nakamura, Yuji, Teppei Fujimoto, Yasuyuki Ogawa, et al.. (2012). Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. ACS Medicinal Chemistry Letters. 3(9). 754–758. 11 indexed citations

Oitate, Masataka, Noriko Masubuchi, Takashi Ito, et al.. (2011). Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data. Drug Metabolism and Pharmacokinetics. 26(4). 423–430. 60 indexed citations

Mori, Kazuhiko, Kiyonori Kai, Hiroko Kataoka, et al.. (2008). The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats. Toxicology and Applied Pharmacology. 232(2). 280–291. 18 indexed citations

Masubuchi, Noriko, et al.. (2007). Prediction of in Vivo Potential for Metabolic Activation of Drugs into Chemically Reactive Intermediate: Correlation of in Vitro and in Vivo Generation of Reactive Intermediates and in Vitro Glutathione Conjugate Formation in Rats and Humans. Chemical Research in Toxicology. 20(3). 455–464. 81 indexed citations

Masubuchi, Noriko. (2006). Risk assessment of human myelotoxicity of anticancer drugs: a predictive model and the in vitro colony forming unit granulocyte/macrophage (CFU-GM) assay.. PubMed. 61(2). 135–9. 4 indexed citations

Masubuchi, Noriko. (2004). Pharmacokinetics of DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f, in tumor-bearing mice.. PubMed. 59(5). 374–7. 6 indexed citations

10.

Inoue, Kazuhiro, et al.. (2004). CM-Dextran-Polyalcohol-Camptothecin Conjugate. Advances in experimental medicine and biology. 519. 145–153. 26 indexed citations

11.

Masubuchi, Noriko, Richard May, & Ryo Atsumi. (2004). A Predictive Model of Human Myelotoxicity Using Five Camptothecin Derivatives and the In vitro Colony-Forming Unit Granulocyte/Macrophage Assay. Clinical Cancer Research. 10(19). 6722–6731. 24 indexed citations

12.

Masubuchi, Noriko, et al.. (1998). Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats. Chirality. 10(8). 747–753. 27 indexed citations

13.

Masubuchi, Noriko, Albert P. Li, & Osamu Okazaki. (1998). An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes. Chemico-Biological Interactions. 114(1-2). 1–13. 40 indexed citations

14.

Masubuchi, Noriko, Hideo Hakusui, & Osamu Okazaki. (1997). Effects of proton pump inhibitors on thyroid hormone metabolism in rats. Biochemical Pharmacology. 54(11). 1225–1231. 15 indexed citations

15.

Masubuchi, Noriko & Osamu Okazaki. (1997). An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors. Chemico-Biological Interactions. 107(1-2). 63–74. 12 indexed citations

16.

Masubuchi, Noriko, Hideo Hakusui, & Osamu Okazaki. (1997). Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.. PubMed. 25(5). 584–9. 17 indexed citations

17.

Okazaki, Osamu, Nobuyuki Murayama, Noriko Masubuchi, Hiroshi Nomura, & Hideo Hakusui. (1996). Placental transfer and milk secretion of gadodiamide injection in rats.. PubMed. 46(1). 83–6. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact